Johnson & Johnson Innovation together with Janssen Research & Development is proud to launch the IBD QuickFire Challenge: Innovating for Health Equity to better understand the manifestations of IBD and determinants of health disparity in diverse racial and ethnic communities.
Donor Name: Johnson & Johnson Innovation
State: All States
County: All Counties
Type of Grant: Challenge
Deadline: 07/28/2023
Size of the Grant: $250,000
Details:
About 1.3 million people are living with inflammatory bowel disease (IBD) in the United States, and data suggests that adults with IBD are more likely to have other chronic conditions than those without IBD. Adults with IBD are also at an increased risk for certain cancers and are disproportionately impacted by psychosocial disorders including depression and anxiety.
The Johnson & Johnson Innovation believe that in order to help profoundly change the trajectory of health for humanity, they must help address health inequities impacting BIPOC communities. Working together, they can drive a unified effort to create change for historically marginalized communities in the U.S. and beyond.
They are interested in methods, tools and technologies aiming to:
- Better understand the burden of disease, and characterize the role of genetics, environment, and/or social factors on IBD pathogenesis and response to treatment in BIPOC communities, with a specific focus on biomarker identification
- Differentiate patient populations, including the utility of tools and technologies such as non-invasive imaging approaches, predictive analytics, and machine learning to aid in the diagnosis and management of IBD in BIPOC communities
- Identify barriers to the diagnosis, treatment, and management of IBD in BIPOC communities, and develop potential solutions to overcome them
- Develop and implement innovative approaches to engage and educate patients and physicians about IBD in BIPOC communities, overcoming barriers and improving access to treatment and participation in clinical trials.
Funding Information
The innovator(s) with the best potential solution will receive grant funding from a total pool of up to $250,000, access to the global Johnson & Johnson Innovation – JLABS network, and mentorship from experts across The Johnson & Johnson Family of Companies for one year.
Eligibility Criteria
- Potential solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- Alignment with QuickFire Challenge areas of focus on IBD (Ulcerative Colitis and Crohn’s Disease)
- Uniqueness of the idea
- Potential impact on human health with a particular focus on meeting the healthcare needs of BIPOC communities
- Feasibility of the idea
- Thoroughness of approach
- Identification of key resources and a plan to advance idea to achieve next developmental milestone
- Team quality and capabilities.
For more information, visit Johnson & Johnson Innovation.
